McHenryM. C.: Infection Due to Methicillin-Resistance Staphylococcus aureus, Cleveland Clin. Quart.36: 9–16 (Jan.) 1969.
6.
O'TooleR. D.: An Outbreak of Methicillin-Resistant Staphylococcus aureus Infection, J. Amer. Med. Assoc.213: 257–263 (July 13) 1970.
7.
RileyH. D.: Vancomycin and Novobiocin, Med. Clin. N. Amer.54: 1277–1288 (Sept.) 1970.
8.
McCormickM. H.: Vancomycin, A New Antibiotic, Antibiotics Annual 1955–1956:606–611, 1956.
9.
Vancocin HCI package insert (Eli Lilly and Co.), March 13, 1970.
10.
HiggensH. M.: Vancomycin, A New Antibiotic, Antibiotics Annual 1957–1958:906–914, 1958.
11.
MannJ. M.: Stability of Parenteral Solutions of Sodium Cephalothin, Cephaloridine, Potassium Penicillin G (buffered) and Vancomycin Hydrochloride, Amer. J. Hosp. Pharm.28: 760–763 (Oct.) 1971.
12.
MisgenR.: Compatibilities and Incompatibilities of Some Intravenous Solution Admixtures, Amer. J. Hosp. Pharm.22: 92–94 (Feb.) 1965.
13.
PatelJ. A.PhillipsG. L.: A Guide to Physical Compatibility of Intravenous Drug Admixtures, Amer. J. Hosp. Pharm.23: 409–411 (Aug.) 1966.
14.
StromingerJ. L.TipperD. J.: Bacterial Cell Wall Synthesis and Structure in Relation to the Mechanism of Action of Penicillins and Other Antibacterial Agents, Amer. J. Med.39: 708–721 (Nov.) 1965.
15.
JordanD. C.MalloryH. D. C.: Site of Action of Vancomycin on Staphylococcus aureus, Antimicrob. Agents Chemother. 489–494, 1964.
16.
MolanderC. W.: Induction by Antibiotics and Comparative Sensitivity of L-Phase Variants of Staphylococcus aureus, J. Bact.88: 591–594 (Sept.) 1964.
17.
GeraciJ. E.: Some Laboratory and Clinical Experiences with a New Antibiotic, Vancomycin, Staff Meetings of the Mayo Clinic31: 564–582 (Oct. 17) 1956.
18.
RileyHarris D.: Vancomycin and Ristocetin, Pediat. Clin. N. Amer.8: 1073–1090, 1961.
19.
KirbyW. M. M.DivelbissC. L.: Vancomycin: Clinical and Laboratory Studies, Antibiotics Annual 1956–1957:107–117, 1957.
20.
LindholmD. D.MurrayJ. S.: Persistence of Vancomycin in the Blood During Renal Failure and Its Treatment By Hemodialysis, 274: 1047–1051 (May 12) 1966.
21.
GarrodL. P.O'GradyF.: Antibiotic and Chemotherapy, 3rd ed., E. and S. Livingston, Edinburg, and London, Great Britain, 1971, p. 230–234.
22.
MorrisA. J.BilinskyR. T.: Prevention of Staphylococcal Shunt Infections By Continuous Vancomycin Prophylaxis, Amer. J. Med. Sci.262: 87–92 (Aug.) 1971.
23.
EykynS.: Vancomycin for Staphylococcal Shunt Site Infections in Patients on Regular Haemodialysis, Brit. Med. J.3: 80–82 (July 11) 1970.
24.
BoenS. T.: Peritoneal Dialysis in Clinical Medicine, 1st ed., Charles C. Thomas, Publisher, Springfield, Ill., 1964, p. 60.
25.
GeraciJ. E.: Antibiotic Therapy of Bacterial Endocarditis VII. Vancomycin for Acute Micrococcal Endocarditis, Staff Meetings of the Mayo Clinic33: 172–181 (Apr. 2) 1958.
26.
SpearsR. L.KochR.: The Use of Vancomycin in Pediatrics, Antibiotics Annual 1959–1960:798–803, 1960.
27.
KirbyW. M. M.: Present Status of Vancomycin Therapy of Staphylococcal and Streptococcal Infections, Antibiotics Annual 1958–1959:580, 1959.
28.
HawleyH. B.GumpD. W.: Vancomycin Therapy of Bacterial Meningitis, Amer. J. Dis. Child.126: 261–264 (Aug). 1973.
29.
GeorgeR. M.: Epidemic Meningitis of the Newborn Caused by Flavobacteria: II. Clinical Manifestations and Treatment. Amer. J. Dis. Child101: 296–304, 1961.
30.
PlotkinS. A.McKitrickJ. C.: Nosocomial Meningitis of the Newborn Caused by a Flavobacterium, J. Amer. Med. Assoc.198: 194–196, 1966.
31.
FurgiueleF. P.: New Antibiotics: Their Intraocular Penetration, Amer. J. Ophthalmol.58: 443–447, 1964.
32.
KirbyW. M. M.: Antibiotic Therapy for Staphylococcal Diseases, New York, Medical Encyclopedia, Inc., 1959, p. 123–137.
33.
EhrenkranzN. J.: The Clinical Evaluation of Vancomycin in the Treatment of Multi-Antibiotic Refractory Staphylococcal Infections, Antibiotics Annual 1958–1959:587–594, 1959.
34.
KirbyW. M. M.: Treatment of Staphylococcal Septicemia with Vancomycin, N. Engl. J. Med.262: 49–55 (Jan. 14) 1960.
35.
GeraciJ. E.HeilmanF. R.: Vancomycin in the Treatment of Staphylococcal Endocarditis, Staff Meetings May Clinic35: 316–326 (June 8) 1960.
36.
WaisbrenB. A.: Comparative Clinical Effectiveness and Toxicity of Vancomycin, Ristocetin, and Kanamycin, Arch. Intern. Med.106: 179–193 (Aug.) 1960.
37.
WoodleyD. W.HallW. H.: The Treatment of Severe Staphylococcal Infections with Vancomycin, Ann. Intern. Med.55: 235–249 (Aug.) 1961.
38.
FriedbergC. K.: Vancomycin Therapy for Enterococcal and Streptococcus Viridans Endocarditis, Arch. Intern. Med.122: 134–140 (Aug.) 1968.
39.
WallaceI. R.CarsonN. A. J.: Staphylococcal Septicaemia Treated with Vancomycin in the Presence of Chronic Renal Failure, Lancet1: 519–520 (Mar. 5) 1960.
40.
RileyH. D.RyanN. J.: Treatment of Severe Staphylococcal Infections in Infancy and Childhood with VancomycinAntibiotics Annual 1959–1960:908–916, 1960.
41.
HughesR. K.: A Method of Improved Antisepsis for Open-Heart Surgery, Ann. Thorac. Surg.2: 230–236 (Mar.) 1966.
KhanM. Y.HallW. H.: Staphylococcal Enterocolitis-Treatment with Oral Vancomycin, Ann. Intern. Med.65: 1–8 (July) 1966.
51.
EckerJ. A.: Pseudomembraneous Enterocolitis —An Unwelcome Gastrointestinal Complication of Antibiotic Therapy, Amer. J. Gastroenterol.54: 214–228 (Sept.) 1970.
52.
WallaceJ. F.: Oral Administration of Vancomycin in the Treatment of Staphylococcal Enterocolitis, N. Engl. J. Med.272: 1014–1015 (May 13) 1965.
53.
JacksonE. A.McLeodD. C.: Pharmacokinetics and Dosing of Antimicrobial Agents in Renal Impairment, Part II, Amer. J. Hosp. Pharm.31: 137–148 (Feb.) 1974.
54.
ZimentI.: Which Antibiotics Are Best for the Patient with Renal Insufficiency?, Med. Times99: 48–60 (May) 1971.
55.
RothenbergH. J.: Anaphylactoid Reaction to Vancomycin, J. Amer. Med. Assoc.171: 1101–1102 (Oct. 24) 1959.